ArticleScience advances2026

Persistent TOP1 cleavage complexes in drug-tolerant cells drive adaptive resistance to EGFR-targeted therapies in lung cancer.

Mathéa Geraud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.